HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benign and malignant vascular tumors of the liver in adults.

Abstract
Vascular tumors of the liver in adult patients include cavernous hemangioma, a common benign tumor; epithelioid hemangioendothelioma, a rare, usually low-grade malignant tumor; and angiosarcoma, a rare and very aggressive tumor. All these primary mesenchymal tumors develop on a normal liver and may also affect other organs. Their pathogenesis remains largely unknown. Hepatic tumors are increasingly detected incidentally due to widespread use of modern abdominal imaging techniques. Therefore, reliable noninvasive characterization and differentiation of such liver tumors is of major importance for clinical practice. Hemangioma follows a benign course, and a nonoperative approach for the majority of these lesions is recommended. A definitive diagnosis of epithelioid hemangioendothelioma and angiosarcoma requires histopathologic examination. Liver transplantation at an early stage has greatly improved the prognosis of epithelioid hemangioendothelioma. The prognosis of angiosarcoma remains dismal. Designing a worldwide database that contains all data about patients with these rare diseases is recommended.
AuthorsPaulette Bioulac-Sage, Hervé Laumonier, Christophe Laurent, Jean Frédéric Blanc, Charles Balabaud
JournalSeminars in liver disease (Semin Liver Dis) Vol. 28 Issue 3 Pg. 302-14 (Aug 2008) ISSN: 0272-8087 [Print] United States
PMID18814083 (Publication Type: Journal Article, Review)
Topics
  • Adult
  • Hemangioendothelioma, Epithelioid (pathology, therapy)
  • Hemangioma, Cavernous (pathology, therapy)
  • Hemangiosarcoma (pathology, therapy)
  • Hepatic Stellate Cells (pathology)
  • Humans
  • Liver (blood supply)
  • Liver Neoplasms (pathology, therapy)
  • Neoplasms, Vascular Tissue (pathology, therapy)
  • Sarcoma, Kaposi (pathology, therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: